FIELD: biotechnology; chemistry.
SUBSTANCE: invention relates to biochemistry, particularly to an anti-IgE antibody or an antigen-binding agent. Also disclosed is an isolated DNA molecule coding said antibody; a vector for cloning or expressing said antibody; pharmaceutical composition containing said antibody. Disclosed is the use of said antibodies and compositions for treatment.
EFFECT: invention enables effective treatment of diseases using said anti-IgE antibody.
12 cl, 16 dwg, 13 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IgE Fc RECEPTOR, A PHARMACEUTICAL COMPOSITION CONTAINING IT AND A METHOD FOR ITS PRODUCTION | 2019 |
|
RU2796162C2 |
| ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR AND THEIR USE | 2016 |
|
RU2815681C1 |
| CD47-ANTIGEN-BINDING UNIT AND ITS USE | 2018 |
|
RU2780859C2 |
| COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS | 2015 |
|
RU2764981C1 |
| COMPOSITION CONTAINING PROBIOTICS AND POLYPEPTIDE HAVING BINDING AFFINITY RELATIVELY TO IgE AND ITS USE | 2019 |
|
RU2786578C2 |
| Fc FUSION HIGH AFFINITY IgE RECEPTOR α-CHAIN | 2016 |
|
RU2715606C2 |
| ANTIGEN-BINDING PROTEINS AGAINST TIGIT AND THEIR APPLICATION METHODS | 2018 |
|
RU2776714C2 |
| CD131-BINDING PROTEINS AND THEIR APPLICATIONS | 2016 |
|
RU2773927C2 |
| BISPECIFIC ANTIGEN-BINDING MOLECULES CONTAINING ANTI-FAP CLONE 212 | 2019 |
|
RU2799429C2 |
| ANTI-IL31 ANTIBODIES FOR VETERINARY USE | 2018 |
|
RU2795485C2 |
